Official Title
A Comparison of Antibody Response Against SARS-CoV-2 in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.
Brief Summary

This is prospective cohort study aimed to compare antibody response against SARS-CoV-2 in dialysis patients and non-dialysis-dependent volunteers. The research hypothesis is that dynamic of IgG antibodies against SARS-CoV-2 will differ in two groups. To determine whether there is a statistically significant interaction between factors "group" and "time" on the titer of IgG antibodies against SARS-CoV-2, a two-way repeated measures ANOVA will be used.

Detailed Description

In both groups level of IgG antibodies against SARS-CoV-2 will be measured at the Day 1 (10
weeks from the date of first symptoms), Weeks 8 and 16 from the Day 1.

Status
Completed
Conditions
Dialysis
COVID19
Eligibility Criteria

Inclusion Criteria:

- Age 18 years or older

- SARS-CoV-2 infection within 10 weeks prior enrollment, confirmed by PCR or strongly
suspected on computed tomography

- Providing informed consent

Exclusion Criteria:

- Refusal to provide informed consent

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Russian Federation
Locations

Saint-Petersburg State University Hospital
Saint Petersburg, Russian Federation

Sponsors / Collaborators
Saint Petersburg State University, Russia
NCT Number
NCT04633915
Keywords
Antibodies
IgG
CKD
Hemodialysis
MeSH Terms
COVID-19